ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

VERU Veru Inc

1,52
0,03 (2,01%)
Pré-mercado
Última atualização: 06:49:07
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Veru Inc VERU NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,03 2,01% 1,52 06:49:07
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,49
mais cotações »

Notícias Recentes

Data Hora Fonte Título
01/05/202409:30GLOBEVeru to Report Fiscal 2024 Second Quarter Financial Results..
30/04/202409:30GLOBEVeru Enrolls First Patients in Phase 2b Clinical Trial of..
25/04/202409:30GLOBEVeru to Present at the American Association of Clinical..
01/04/202417:05GLOBEVeru Announces Date of 2024 Annual Meeting of Shareholders
22/03/202417:05GLOBEVeru Reschedules Annual Meeting of Shareholders
12/03/202409:00GLOBEVeru Announces the Appointment of Louis Aronne MD as Chief..
27/02/202421:15GLOBEVeru Announces Notification from Nasdaq Related to Delayed..
20/02/202410:30GLOBEVeru Announces New Scientific Advisory Board for its..
08/02/202408:30GLOBEVeru Reports Fiscal 2024 First Quarter Financial Highlights
06/02/202410:30GLOBEVeru Announces FDA Clearance of IND Application to Initiate..
31/01/202410:30GLOBEVeru to Present at the Oppenheimer 34th Annual Healthcare..
25/01/202410:30GLOBEVeru to Report Fiscal 2024 First Quarter Financial Results..
08/01/202410:30GLOBEVeru Submits IND Application to FDA for the Development of..
19/12/202310:30GLOBEVeru to Host Investor Call on January 4th, 2024 to Discuss..
14/12/202311:00GLOBEVeru Announces Pricing of Public Offering of Common Stock
13/12/202318:01GLOBEVeru Announces Proposed Public Offering of Common Stock
04/10/202309:30GLOBEVeru Reports Muscle Data from 5 Clinical Studies of..
26/09/202309:30GLOBEVeru Reaches Agreement with FDA on New Phase 3 Clinical..
20/09/202309:30GLOBEVeru to Participate in Fireside Chat at the 2023 Cantor..
11/09/202308:00GLOBEVeru Reports Clinical Data from the Discontinued ARTEST..
30/08/202309:30GLOBEVeru to Present at the H.C. Wainwright 25th Annual Global..
10/08/202307:30GLOBEVeru Reports Fiscal 2023 Third Quarter Financial Results
03/08/202309:30GLOBEVeru to Report Fiscal 2023 Third Quarter Financial Results..
21/06/202309:30GLOBEVeru Inc.’s Oncology Drug Research Program Partner, The..
01/06/202309:30GLOBEVeru Announces Appointment of Dr. Erik Swenson and Dr...
24/05/202309:30GLOBEVeru to Present at the Jefferies Healthcare Conference
11/05/202307:30GLOBEVeru Reports Fiscal 2023 Second Quarter Financial Results
04/05/202309:30GLOBEVeru Reaches Agreement with FDA on Confirmatory Phase 3..
03/05/202309:30GLOBEVeru Enters into Common Stock Purchase Agreement for Up to..

Seu Histórico Recente

Delayed Upgrade Clock